Observational Study
Copyright ©The Author(s) 2021.
World J Nephrol. Mar 25, 2021; 10(2): 8-20
Published online Mar 25, 2021. doi: 10.5527/wjn.v10.i2.8
Figure 1
Figure 1 The patient population in this study. CAG: Coronary angiography; eGFR: Estimated glomerular filtration rate; LMWD: Low-molecular-weight dextran; OCT: Optical coherence tomography; PCI: Percutaneous coronary intervention.
Figure 2
Figure 2 Serial comparison of serum creatinine levels at baseline, and within 5 d, 1 mo, and 1-year post-procedure. A: Entire study cohort. Renal function was consistently lower in the low-molecular-weight dextran (LMWD) group than in the control group; B: Propensity score-matched cohort. The LMWD group demonstrated a trend toward worsening renal insufficiency during the 1-year follow-up compared with the control group. LMWD: Low-molecular-weight dextran.
Figure 3
Figure 3 Prevalence of worsening renal function stratified by the cut-off values for low-molecular-weight dextran volume and baseline estimated glomerular filtration rate level in propensity score-matched cohort. eGFR: Estimated glomerular filtration rate; LMWD: Low-molecular-weight dextran.